Company Overview
SciGen is a biopharmaceutical company committed to delivering innovative and affordable healthcare solutions to patients worldwide.
Founded in Singapore in 1988, SciGen combines strong commercialization capabilities, regulatory expertise, and global partnerships to in-license, develop, and distribute branded pharmaceuticals and medical devices in key therapeutic areas, including endocrinology, hematology, and oncology.
With direct operations in Singapore, South Korea, Australia, China, Thailand, Vietnam and Philippines, and a commercial footprint across all six continents through commercial partnerships, we connect global innovation with local patient needs.
Our specialty pharmaceutical platform is strengthened by a growing biologics and biotechnology capability, enabling us to continuously expand our pipeline and improve access to high-quality therapies.
Through close collaboration with industry partners and academic institutions, we work to accelerate innovation and ensure that patients receive the treatments they need.
At SciGen, healthcare is more than a business — it is our mission. Guided by humility, service, and scientific excellence, we strive to improve patient outcomes and bring hope to patients and their families around the world.
Commercialization
Outstanding Marketing & Sales team with strong penetration across key emerging markets.
Alliance
Robust alliance management capabilities.
Partnership
Excellent network of regional partners.
Regulatory
Extensive experience in regulatory process.
History Timeline
Our Global Presence
Philippines
Australia
China
Thailand
Vietnam
South Korea
Poland
Italy
